Pulmonary/Respiratory Drug Delivery Market Report

Global and Region Pulmonary/Respiratory Drug Delivery Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：219
  • REPORT CODE：GMM896667
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Pulmonary/Respiratory Drug Delivery market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Pulmonary/Respiratory Drug Deliverymarket, defines the market attractiveness level of Pulmonary/Respiratory Drug Delivery market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Pulmonary/Respiratory Drug Delivery industry, describes the types of Pulmonary/Respiratory Drug Delivery market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pulmonary/Respiratory Drug Delivery market and the development prospects and opportunities of Pulmonary/Respiratory Drug Delivery industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pulmonary/Respiratory Drug Delivery market in Chapter 13.

    By Player:

    • 3M (US)

    • Merck & Co, Inc (US)

    • Omron Corporation (Japan)

    • Boehringer Ingelheim GmbH (Germany)

    • Novartis AG (Switzerland)

    • AstraZeneca plc (UK)

    • Sunovion Pharmaceuticals Inc (US)

    • Teva Pharmaceutical Industries Ltd (Israel)

    • GlaxoSmithKline (UK)

    By Type:

    • Suspension Aerosol

    • Solution Aerosol

    • Dry Powder Formulation

    By End-User:

    • Hospitals

    • Home Care

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Pulmonary/Respiratory Drug Delivery Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Pulmonary/Respiratory Drug Delivery Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Pulmonary/Respiratory Drug Delivery Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Pulmonary/Respiratory Drug Delivery Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Pulmonary/Respiratory Drug Delivery Market Analysis and Outlook to 2022

    • 7.1 Global Pulmonary/Respiratory Drug Delivery Consumption (2017-2022)

    • 7.2 United States Pulmonary/Respiratory Drug Delivery Consumption (2017-2022)

    • 7.3 Europe Pulmonary/Respiratory Drug Delivery Consumption (2017-2022)

    • 7.4 China Pulmonary/Respiratory Drug Delivery Consumption (2017-2022)

    • 7.5 Japan Pulmonary/Respiratory Drug Delivery Consumption (2017-2022)

    • 7.6 India Pulmonary/Respiratory Drug Delivery Consumption (2017-2022)

    • 7.7 South Korea Pulmonary/Respiratory Drug Delivery Consumption (2017-2022)

    8 Region and Country-wise Pulmonary/Respiratory Drug Delivery Market Analysis and Outlook to 2028

    • 8.1 Global Pulmonary/Respiratory Drug Delivery Consumption Forecast (2022-2028)

    • 8.2 United States Pulmonary/Respiratory Drug Delivery Consumption Forecast (2022-2028)

    • 8.3 Europe Pulmonary/Respiratory Drug Delivery Consumption Forecast (2022-2028)

    • 8.4 China Pulmonary/Respiratory Drug Delivery Consumption Forecast (2022-2028)

    • 8.5 Japan Pulmonary/Respiratory Drug Delivery Consumption Forecast (2022-2028)

    • 8.6 India Pulmonary/Respiratory Drug Delivery Consumption Forecast (2022-2028)

    • 8.7 South Korea Pulmonary/Respiratory Drug Delivery Consumption Forecast (2022-2028)

    9 Global Pulmonary/Respiratory Drug Delivery Market Outlook by Types and Applications to 2022

    • 9.1 Global Pulmonary/Respiratory Drug Delivery Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Suspension Aerosol Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Solution Aerosol Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Dry Powder Formulation Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pulmonary/Respiratory Drug Delivery Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Home Care Consumption and Growth Rate (2017-2022)

    10 Global Pulmonary/Respiratory Drug Delivery Market Outlook by Types and Applications to 2028

    • 10.1 Global Pulmonary/Respiratory Drug Delivery Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Suspension Aerosol Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Solution Aerosol Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Dry Powder Formulation Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Pulmonary/Respiratory Drug Delivery Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Home Care Consumption Forecast and Growth Rate (2022-2028)

    11 Global Pulmonary/Respiratory Drug Delivery Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Pulmonary/Respiratory Drug Delivery Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Pulmonary/Respiratory Drug Delivery Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Pulmonary/Respiratory Drug Delivery Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Pulmonary/Respiratory Drug Delivery Market Competitive Analysis

    • 14.1 3M (US)

      • 14.1.1 3M (US) Company Details

      • 14.1.2 3M (US) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 3M (US) Pulmonary/Respiratory Drug Delivery Product and Service

    • 14.2 Merck & Co, Inc (US)

      • 14.2.1 Merck & Co, Inc (US) Company Details

      • 14.2.2 Merck & Co, Inc (US) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck & Co, Inc (US) Pulmonary/Respiratory Drug Delivery Product and Service

    • 14.3 Omron Corporation (Japan)

      • 14.3.1 Omron Corporation (Japan) Company Details

      • 14.3.2 Omron Corporation (Japan) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Omron Corporation (Japan) Pulmonary/Respiratory Drug Delivery Product and Service

    • 14.4 Boehringer Ingelheim GmbH (Germany)

      • 14.4.1 Boehringer Ingelheim GmbH (Germany) Company Details

      • 14.4.2 Boehringer Ingelheim GmbH (Germany) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Boehringer Ingelheim GmbH (Germany) Pulmonary/Respiratory Drug Delivery Product and Service

    • 14.5 Novartis AG (Switzerland)

      • 14.5.1 Novartis AG (Switzerland) Company Details

      • 14.5.2 Novartis AG (Switzerland) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novartis AG (Switzerland) Pulmonary/Respiratory Drug Delivery Product and Service

    • 14.6 AstraZeneca plc (UK)

      • 14.6.1 AstraZeneca plc (UK) Company Details

      • 14.6.2 AstraZeneca plc (UK) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AstraZeneca plc (UK) Pulmonary/Respiratory Drug Delivery Product and Service

    • 14.7 Sunovion Pharmaceuticals Inc (US)

      • 14.7.1 Sunovion Pharmaceuticals Inc (US) Company Details

      • 14.7.2 Sunovion Pharmaceuticals Inc (US) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sunovion Pharmaceuticals Inc (US) Pulmonary/Respiratory Drug Delivery Product and Service

    • 14.8 Teva Pharmaceutical Industries Ltd (Israel)

      • 14.8.1 Teva Pharmaceutical Industries Ltd (Israel) Company Details

      • 14.8.2 Teva Pharmaceutical Industries Ltd (Israel) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Teva Pharmaceutical Industries Ltd (Israel) Pulmonary/Respiratory Drug Delivery Product and Service

    • 14.9 GlaxoSmithKline (UK)

      • 14.9.1 GlaxoSmithKline (UK) Company Details

      • 14.9.2 GlaxoSmithKline (UK) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GlaxoSmithKline (UK) Pulmonary/Respiratory Drug Delivery Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Pulmonary/Respiratory Drug Delivery

    • Figure Pulmonary/Respiratory Drug Delivery Picture

    • Table Global Pulmonary/Respiratory Drug Delivery Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pulmonary/Respiratory Drug Delivery Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pulmonary/Respiratory Drug Delivery Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Pulmonary/Respiratory Drug Delivery Consumption by Country (2017-2022)

    • Figure United States Pulmonary/Respiratory Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table Europe Pulmonary/Respiratory Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure China Pulmonary/Respiratory Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Japan Pulmonary/Respiratory Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure India Pulmonary/Respiratory Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pulmonary/Respiratory Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Global Pulmonary/Respiratory Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure United States Pulmonary/Respiratory Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pulmonary/Respiratory Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Pulmonary/Respiratory Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pulmonary/Respiratory Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pulmonary/Respiratory Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pulmonary/Respiratory Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Suspension Aerosol Consumption and Growth Rate (2017-2022)

    • Figure Global Solution Aerosol Consumption and Growth Rate (2017-2022)

    • Figure Global Dry Powder Formulation Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Home Care Consumption and Growth Rate (2017-2022)

    • Figure Global Suspension Aerosol Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Solution Aerosol Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dry Powder Formulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Pulmonary/Respiratory Drug Delivery Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Pulmonary/Respiratory Drug Delivery Export by Region (Top 5 Countries) (2017-2028)

    • Table 3M (US) (Foundation Year, Company Profile and etc.)

    • Table 3M (US) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3M (US) Pulmonary/Respiratory Drug Delivery Product and Service

    • Table Merck & Co, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc (US) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc (US) Pulmonary/Respiratory Drug Delivery Product and Service

    • Table Omron Corporation (Japan) (Foundation Year, Company Profile and etc.)

    • Table Omron Corporation (Japan) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Omron Corporation (Japan) Pulmonary/Respiratory Drug Delivery Product and Service

    • Table Boehringer Ingelheim GmbH (Germany) (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim GmbH (Germany) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH (Germany) Pulmonary/Respiratory Drug Delivery Product and Service

    • Table Novartis AG (Switzerland) (Foundation Year, Company Profile and etc.)

    • Table Novartis AG (Switzerland) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG (Switzerland) Pulmonary/Respiratory Drug Delivery Product and Service

    • Table AstraZeneca plc (UK) (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca plc (UK) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca plc (UK) Pulmonary/Respiratory Drug Delivery Product and Service

    • Table Sunovion Pharmaceuticals Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Sunovion Pharmaceuticals Inc (US) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sunovion Pharmaceuticals Inc (US) Pulmonary/Respiratory Drug Delivery Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Israel) (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd (Israel) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd (Israel) Pulmonary/Respiratory Drug Delivery Product and Service

    • Table GlaxoSmithKline (UK) (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline (UK) Pulmonary/Respiratory Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline (UK) Pulmonary/Respiratory Drug Delivery Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US